# Cross-Sectional Imaging in Urology: CT and MRI Fundamentals

## Introduction

Cross-sectional imaging plays a crucial role in contemporary urologic practice. Both computed tomography (CT) and magnetic resonance imaging (MRI) offer detailed anatomical and functional insights that are essential for accurate diagnosis, staging of disease, and surgical planning. It is important for urologists to grasp the fundamental principles underlying these imaging modalities, understand their appropriate clinical uses, and be able to interpret key findings effectively. Proficiency in ordering and interpreting urologic imaging studies helps to minimize diagnostic delays and enhances patient outcomes.

## Computed Tomography (CT)

### Basic Principles

CT imaging is based on measuring X-ray attenuation, which is quantified in Hounsfield units (HU). By definition, water has an attenuation of 0 HU, air measures around -1000 HU, and dense bone can reach +1000 HU. Modern CT scanners often use helical or spiral acquisition, where volumetric data are collected continuously as the patient table moves through the scanner. This allows for multiplanar reconstructions of the anatomy. Multi-detector CT (MDCT) technology employs multiple rows of detectors, enabling rapid, high-resolution imaging with thin slices typically ranging from 0.5 to 1.0 millimeters. Radiation dose is an important consideration; a typical CT scan of the abdomen and pelvis delivers approximately 10 to 20 millisieverts (mSv).

### Contrast Protocols for Urologic CT

Different contrast protocols are tailored to specific urologic indications. Non-contrast CT (NCCT) is the gold standard for detecting renal colic and urinary stones, as stones generally appear hyperdense regardless of their composition, with the exception of indinavir stones. The CT urogram provides a comprehensive evaluation of the upper urinary tract and involves multiple phases: a non-contrast phase for stone detection, a nephrographic phase occurring 90 to 120 seconds after contrast administration to characterize renal parenchymal lesions, and an excretory or delayed phase at 7 to 10 minutes to assess the urothelium and collecting system. The split-bolus protocol, which combines phases to reduce radiation exposure, is becoming a standard approach. CT angiography, performed during the arterial phase at 25 to 30 seconds, is used to delineate renal vascular anatomy, evaluate living donors, and identify hemorrhage.

### Key Urologic Applications

In the evaluation of urolithiasis, non-contrast CT offers sensitivity greater than 95% and specificity over 98%. It provides detailed information on stone size, location, density (measured in HU), and skin-to-stone distance, which are important for management decisions. For renal masses, the Bosniak classification system is used to categorize cystic lesions based on their complexity and risk of malignancy. Bosniak I lesions are simple cysts requiring no follow-up, while Bosniak II lesions are minimally complex and also do not require surveillance. Bosniak IIF lesions are mildly complex and warrant follow-up imaging. Bosniak III lesions are indeterminate and may require surgical excision or active surveillance, whereas Bosniak IV lesions exhibit clearly malignant features and typically necessitate surgical removal. CT urography is also essential for staging urothelial carcinoma of the upper tract, where findings such as filling defects, wall thickening, and hydronephrosis are assessed. Adrenal masses are evaluated by measuring unenhanced attenuation; values less than 10 HU suggest lipid-rich adenomas, while washout calculations help characterize indeterminate lesions.

<image>Annotated CT urogram in excretory phase showing normal bilateral renal collecting systems with contrast opacification of ureters and bladder, with labels identifying renal cortex, medulla, renal pelvis, proximal and distal ureters, and bladder</image>

### Radiation Safety and Dose Reduction

Radiation safety follows the ALARA principle—As Low As Reasonably Achievable. Low-dose CT protocols for stone disease have been developed that reduce radiation exposure by 50 to 80% while maintaining diagnostic accuracy. Iterative reconstruction algorithms enable the use of lower tube currents without compromising image quality. Ultrasound remains the preferred first-line imaging modality in children, pregnant women, and young patients with suspected stones to avoid radiation exposure. Dual-energy CT (DECT) is an emerging technology that can differentiate uric acid stones from non-uric acid stones and may reduce the need for additional imaging phases.

## Magnetic Resonance Imaging (MRI)

### Basic Principles

MRI uses strong magnetic fields and radiofrequency pulses to generate images based on the behavior of hydrogen protons within tissues. T1-weighted images show fat as bright and fluid as dark, making them ideal for detailed anatomic visualization. T2-weighted images depict fluid as bright, which is useful for identifying edema, cysts, and pathological changes. MRI does not involve ionizing radiation, making it the preferred imaging modality during pregnancy (without gadolinium contrast), in pediatric patients, and for repeated surveillance studies.

### Key MRI Sequences in Urology

T1-weighted (T1W) sequences provide excellent anatomical detail and are particularly useful for detecting hemorrhage, which appears bright on T1, as well as fat-containing lesions. T2-weighted (T2W) images highlight zonal anatomy of the prostate, characterize renal cysts, and evaluate retroperitoneal pathology. Diffusion-weighted imaging (DWI) detects restricted water diffusion, which is a hallmark of cellular tumors; these areas appear bright on DWI with corresponding low apparent diffusion coefficient (ADC) values. Dynamic contrast-enhanced (DCE) imaging assesses vascular perfusion, where early arterial enhancement is suggestive of malignancy. MR urography can be performed using T2-weighted sequences for non-dilated collecting systems or gadolinium-enhanced sequences for dilated systems.

### Prostate MRI (Multiparametric MRI)

Multiparametric MRI (mpMRI) of the prostate combines T2W, DWI, and DCE sequences to improve detection of clinically significant prostate cancer. The PI-RADS version 2.1 scoring system guides interpretation: scores of 1 to 2 indicate that clinically significant cancer is unlikely; a score of 3 is equivocal; 4 suggests that clinically significant cancer is likely; and 5 indicates a high likelihood of clinically significant cancer. The dominant sequence varies by zone, with T2W images being most important for transition zone lesions and DWI for peripheral zone lesions. mpMRI is instrumental for biopsy targeting using MRI-TRUS fusion techniques and for monitoring patients on active surveillance.

<image>Multiparametric MRI of the prostate showing a PI-RADS 5 lesion in the peripheral zone, with side-by-side panels of T2-weighted (dark focal lesion), DWI (bright signal indicating restricted diffusion), ADC map (dark corresponding region), and DCE (early enhancement), with annotations labeling each sequence and the suspicious lesion</image>

### Renal MRI

MRI is valuable for characterizing indeterminate renal masses when CT findings are inconclusive. Clear cell renal cell carcinoma (RCC) typically appears hyperintense on T2-weighted images, shows avid contrast enhancement, and demonstrates loss of signal on opposed-phase imaging due to intracellular lipid content. Angiomyolipomas can be identified by the presence of macroscopic fat, which produces a characteristic chemical shift artifact known as the India ink artifact. MR angiography allows evaluation of renal artery stenosis without the need for iodinated contrast. Functional MRI techniques can assess renal perfusion and estimate split renal function.

### Contrast Agents and Safety

Gadolinium-based contrast agents (GBCAs) are generally safe and carry a lower risk of allergic reactions compared to iodinated contrast. However, nephrogenic systemic fibrosis (NSF) is a rare but serious complication that can occur in patients with severely reduced kidney function (glomerular filtration rate [GFR] less than 30 mL/min). To minimize this risk, Group II GBCAs such as gadobutrol and gadoterate, which have the lowest NSF risk, are preferred. Iodinated contrast carries a risk of contrast-induced nephropathy (CIN) in patients with eGFR below 30 mL/min, and pre-hydration with isotonic saline is protective. Metformin should be withheld for 48 hours after iodinated contrast administration in patients with eGFR less than 30 mL/min to reduce the risk of lactic acidosis.

## Choosing Between CT and MRI

When deciding between CT and MRI, several factors must be considered. CT is a fast imaging modality, typically completed within seconds, whereas MRI requires a longer acquisition time of 30 to 60 minutes. CT excels at stone detection, while MRI performs poorly in this regard. Soft tissue contrast is good with CT but superior with MRI. CT involves ionizing radiation, whereas MRI does not. For prostate evaluation, MRI, particularly multiparametric MRI, is superior. CT is the first-line modality for renal mass characterization, with MRI reserved for problem-solving. Claustrophobia and the presence of implants do not affect CT but can limit MRI use. Finally, CT is generally less expensive than MRI.

| Feature | CT | MRI |
|---|---|---|
| Acquisition time | Seconds | 30-60 minutes |
| Stone detection | Excellent (>95% sensitivity) | Poor |
| Soft tissue contrast | Good | Superior |
| Ionizing radiation | Yes (10-20 mSv abdomen/pelvis) | None |
| Prostate evaluation | Limited | Superior (mpMRI with PI-RADS) |
| Renal mass characterization | First-line | Problem-solving for indeterminate lesions |
| Claustrophobia/implants | Not a limitation | Can limit use |
| Cost | Lower | Higher |
| Contrast risk | CIN (eGFR <30) | NSF (eGFR <30, Group I agents) |

| Bosniak Class | Features | Management |
|---|---|---|
| I | Simple cyst; thin wall, no septa/calcification/enhancement | No follow-up |
| II | Minimally complex; few thin septa, fine calcification, no enhancement | No follow-up |
| IIF | Mildly complex; multiple thin septa, minimal thickening, no enhancement | Follow-up imaging |
| III | Indeterminate; thick septa/wall, measurable enhancement | Surgery or active surveillance |
| IV | Clearly malignant; enhancing soft tissue component | Surgical excision |

<image>Side-by-side comparison of a CT scan and MRI of the same patient with a complex renal mass, showing the superior soft tissue contrast resolution of MRI in distinguishing tumor from normal parenchyma, with labeled anatomic landmarks</image>

## Key Clinical Pearls

Non-contrast CT remains the gold standard for evaluating acute renal colic, and low-dose protocols should be routinely employed to minimize radiation exposure. On CT, an enhancement greater than 20 HU is the accepted threshold to distinguish a solid renal mass from a hyperdense cyst. The PI-RADS version 2.1 scoring system on prostate multiparametric MRI guides biopsy decisions, with the dominant imaging sequence differing by prostate zone—T2-weighted imaging for the transition zone and diffusion-weighted imaging for the peripheral zone. It is essential to assess renal function before administering contrast agents, using glomerular filtration rate thresholds to guide the use of iodinated and gadolinium-based contrast. Dual-energy CT is an emerging technology that aids in stone composition analysis and can provide virtual non-contrast images, potentially reducing radiation dose.

## References

1. Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. *Radiology*. 2019;292(2):475-488.  
2. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2. *Eur Urol*. 2019;76(3):340-351.  
3. Smith-Bindman R, Aubin C, Bailitz J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. *N Engl J Med*. 2014;371(12):1100-1110.  
4. Davenport MS, Perazella MA, Yee J, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. *Radiology*. 2020;294(3):660-668.